Coronavirus guidance

If you think you may have symptoms of Coronavirus >, follow the national guidance and self-isolate for 10 days. Please see our information on Coronavirus and changes to our normal services >. If you, or a member of your family has tested positive for Coronavirus, please find resources to aid your/their recovery on our Coronavirus - Supporting your recovery > page.

Bibliograhpy

We have published a range of journal articles from data collected from the RRID study. Additionally, many results have been presented at national and international conferences. Journal articles published are listed below.
 

  1. Shardlow A, McIntyre NJ, Fraser SDS, Roderick P, Raftery J, Fluck RJ, McIntyre CW, Taal MW. The clinical utility and cost impact of cystatin C measurement in the diagnosis and management of chronic kidney disease: A primary care cohort study. PLoS Med. 2017 Oct 10;14(10): e1002400.
     
  2. Shardlow A, McIntyre NJ, Fluck RJ, McIntyre CW, Taal MW (2016) Chronic Kidney Disease in Primary Care: Outcomes after Five Years in a Prospective Cohort Study. PLoS Med 13(9): e1002128. doi: 10.1371/journal.pmed.1002128
     
  3. Fraser SD, Roderick PJ, May CR, McIntyre N, McIntyre C, Fluck RJ, Shardlow A, Taal MW. The burden of comorbidity in people with chronic kidney disease stage 3: a cohort study. BMC Nephrol. 2015 Dec 1;16:193.
     
  4. Nerbass FB, Pecoits-Filho R, McIntyre NJ, Shardlow A, McIntyre CW, Taal MW. Reduction in sodium intake is independently associated with improved blood pressure control in people with chronic kidney disease in primary care. Br J Nutr. 2015 Sep 28;114(6):936-42.
     
  5. Assi LK, McIntyre N, Fraser S, Harris S, Hutchison CA, McIntyre CW, Cockwell P, Taal MW. The Association between Polyclonal Combined Serum Free Light Chain Concentration and Mortality in Individuals with Early Chronic Kidney Disease. PLoS One. 2015 Jul 1;10(7):e0129980.
     
  6. Nerbass FB, Pecoits-Filho R, McIntyre NJ, McIntyre CW, Taal MW. High sodium intake is associated with important risk factors in a large cohort of chronic kidney disease patients. Eur J Clin Nutr. 2015 Jul;69(7):786-90.
     
  7. Nerbass FB, Pecoits-Filho R, McIntyre NJ, McIntyre CW, Willingham FC, Taal MW. Demographic associations of high estimated sodium intake and frequency of consumption of high-sodium foods in people with chronic kidney disease stage 3 in England. J Ren Nutr. 2014 Jul;24(4):236-42. doi: 10.1053/j.jrn.2014.03.003.
     
  8. Fraser SD, Roderick PJ, McIntyre NJ, Harris S, McIntyre C, Fluck R, Taal MW. Assessment of proteinuria in patients with chronic kidney disease stage 3: albuminuria and non-albumin proteinuria. PLoS One. 2014 May 27;9(5):e98261.
     
  9. Nerbass FB, Pecoits-Filho R, McIntyre NJ, McIntyre CW, Taal MW. Development of a formula for estimation of sodium intake from spot urine in people with chronic kidney disease. Nephron Clin Pract. 2014;128(1-2):61-6.
     
  10. Taal MW, Thurston V, McIntyre NJ, Fluck RJ, McIntyre CW. Impact of Vitamin D Status on the Relative Increase in Fibroblast Growth Factor 23 and Parathyroid Hormone in Chronic Kidney Disease. Kidney Int; published online 15 Jan 2014.
     
  11. Fraser SD, Roderick PJ, McIntyre NJ, Harris S, McIntyre CW, Fluck RJ, Taal MW. Suboptimal blood pressure control in chronic kidney disease stage 3: baseline data from a cohort study in primary care. BMC Fam Pract. 2013 Jun 24;14:88.
     
  12. McIntyre NJ, Fluck RJ, McIntyre CW, Fakis A, Taal MW. Determinants of arterial stiffness in chronic kidney disease stage 3. PLoS One. 2013;8(1):e55444.
     
  13. Fraser SD, Roderick PJ, McIntyre NJ, Harris S, McIntyre CW, Fluck RJ, Taal MW. Socio-economic disparities in the distribution of cardiovascular risk in chronic kidney disease stage 3. Nephron Clin Pract. 2012;122(1-2):58-65.
     
  14. McIntyre NJ, Fluck R, McIntyre C, Taal M. Treatment needs and diagnosis awareness in primary care patients with chronic kidney disease. Br J Gen Pract. 2012 Apr;62(597):e227-32.
     
  15. Evans PD, McIntyre NJ, Fluck RJ, McIntyre CW, Taal MW. Anthropomorphic measurements that include central fat distribution are more closely related with key risk factors than BMI in CKD stage 3. PLoS One. 2012;7(4):e34699.
     
  16. McIntyre NJ, Fluck RJ, McIntyre CW, Taal MW. Skin autofluorescence and the association with renal and cardiovascular risk factors in chronic kidney disease stage 3. Clin J Am Soc Nephrol. 2011 Oct;6(10):2356-63.
     
  17. McIntyre NJ, Fluck RJ, McIntyre CW, Taal MW. Risk profile in chronic kidney disease stage 3: older versus younger patients. Nephron Clin Pract. 2011;119(4):c269-76.